Moelis hires former Morgan Stanley bankers for healthcare dealmaking By Reuters

By David Carnevali

NEW YORK (Reuters) – Moelis (NYSE:) & Co. has employed two former Morgan Stanley (NYSE:) bankers, Arek Kurkciyan and Dennis Crandall, as managing administrators to assist drive dealmaking within the life sciences and outsourced pharmaceutical companies sectors for the funding financial institution.

Kurkciyan and Crandall will begin their new roles in late November and be based mostly in New York, in response to a memo seen by Reuters on Tuesday. Each Kurkciyan and Crandall had been managing administrators within the healthcare funding banking unit at Morgan Stanley.

“Arek and Dennis carry sturdy relationships with each large-cap corporates and personal fairness buyers which might be core to our Agency’s technique,” mentioned Jeff Raich, co-President at Moelis.

Of their earlier roles at Morgan Stanley, each bankers labored on vital offers involving giant healthcare companies and monetary sponsors.

They each collectively labored on offers together with the sale of biotech firm Aldevron to medical tools maker Danaher Corp (NYSE:) for $9.6 billion and scientific devices maker Thermo Fisher (NYSE:)’s acquisition of Brammer Bio for roughly $1.7 billion.

In current months, Moelis has been making an attempt to shore up its healthcare M&A unit. It just lately employed one other senior banker Igor Sokolovsky to assist with dealmaking throughout sectors, with a particular deal with healthcare.